Global Pneumonia Therapeutics Market Growth (Status and Outlook) 2022-2028
- LP 4842080
- 85 Pages
- February 2022
- Pharmaceuticals
The United States Pneumonia Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pneumonia Therapeutics market, reaching US$ million by the year 2028. As for the Europe Pneumonia Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pneumonia Therapeutics players cover GlaxoSmithKline, Merck Sharp & Dohme, Novartis, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pneumonia Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Vaccines
Anti-Infectives
Oxygen Therapy
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinic
Medical Center
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline
Merck Sharp & Dohme
Novartis
Pfizer
AstraZeneca
Bayer
Biotest
Tetraphase Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pneumonia Therapeutics Market Size 2017-2028
2.1.2 Pneumonia Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Pneumonia Therapeutics Segment by Type
2.2.1 Vaccines
2.2.2 Anti-Infectives
2.2.3 Oxygen Therapy
2.3 Pneumonia Therapeutics Market Size by Type
2.3.1 Pneumonia Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Pneumonia Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Pneumonia Therapeutics Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Medical Center
2.4.4 Other
2.5 Pneumonia Therapeutics Market Size by Application
2.5.1 Pneumonia Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Pneumonia Therapeutics Market Size Market Share by Application (2017-2022)
3 Pneumonia Therapeutics Market Size by Player
3.1 Pneumonia Therapeutics Market Size Market Share by Players
3.1.1 Global Pneumonia Therapeutics Revenue by Players (2020-2022)
3.1.2 Global Pneumonia Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Pneumonia Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pneumonia Therapeutics by Regions
4.1 Pneumonia Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Pneumonia Therapeutics Market Size Growth (2017-2022)
4.3 APAC Pneumonia Therapeutics Market Size Growth (2017-2022)
4.4 Europe Pneumonia Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Pneumonia Therapeutics Market Size Growth (2017-2022)
5 Americas
5.1 Americas Pneumonia Therapeutics Market Size by Country (2017-2022)
5.2 Americas Pneumonia Therapeutics Market Size by Type (2017-2022)
5.3 Americas Pneumonia Therapeutics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pneumonia Therapeutics Market Size by Region (2017-2022)
6.2 APAC Pneumonia Therapeutics Market Size by Type (2017-2022)
6.3 APAC Pneumonia Therapeutics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pneumonia Therapeutics by Country (2017-2022)
7.2 Europe Pneumonia Therapeutics Market Size by Type (2017-2022)
7.3 Europe Pneumonia Therapeutics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pneumonia Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Pneumonia Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Pneumonia Therapeutics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pneumonia Therapeutics Market Forecast
10.1 Global Pneumonia Therapeutics Forecast by Regions (2023-2028)
10.1.1 Global Pneumonia Therapeutics Forecast by Regions (2023-2028)
10.1.2 Americas Pneumonia Therapeutics Forecast
10.1.3 APAC Pneumonia Therapeutics Forecast
10.1.4 Europe Pneumonia Therapeutics Forecast
10.1.5 Middle East & Africa Pneumonia Therapeutics Forecast
10.2 Americas Pneumonia Therapeutics Forecast by Country (2023-2028)
10.2.1 United States Pneumonia Therapeutics Market Forecast
10.2.2 Canada Pneumonia Therapeutics Market Forecast
10.2.3 Mexico Pneumonia Therapeutics Market Forecast
10.2.4 Brazil Pneumonia Therapeutics Market Forecast
10.3 APAC Pneumonia Therapeutics Forecast by Region (2023-2028)
10.3.1 China Pneumonia Therapeutics Market Forecast
10.3.2 Japan Pneumonia Therapeutics Market Forecast
10.3.3 Korea Pneumonia Therapeutics Market Forecast
10.3.4 Southeast Asia Pneumonia Therapeutics Market Forecast
10.3.5 India Pneumonia Therapeutics Market Forecast
10.3.6 Australia Pneumonia Therapeutics Market Forecast
10.4 Europe Pneumonia Therapeutics Forecast by Country (2023-2028)
10.4.1 Germany Pneumonia Therapeutics Market Forecast
10.4.2 France Pneumonia Therapeutics Market Forecast
10.4.3 UK Pneumonia Therapeutics Market Forecast
10.4.4 Italy Pneumonia Therapeutics Market Forecast
10.4.5 Russia Pneumonia Therapeutics Market Forecast
10.5 Middle East & Africa Pneumonia Therapeutics Forecast by Region (2023-2028)
10.5.1 Egypt Pneumonia Therapeutics Market Forecast
10.5.2 South Africa Pneumonia Therapeutics Market Forecast
10.5.3 Israel Pneumonia Therapeutics Market Forecast
10.5.4 Turkey Pneumonia Therapeutics Market Forecast
10.5.5 GCC Countries Pneumonia Therapeutics Market Forecast
10.6 Global Pneumonia Therapeutics Forecast by Type (2023-2028)
10.7 Global Pneumonia Therapeutics Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Information
11.1.2 GlaxoSmithKline Pneumonia Therapeutics Product Offered
11.1.3 GlaxoSmithKline Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 GlaxoSmithKline Main Business Overview
11.1.5 GlaxoSmithKline Latest Developments
11.2 Merck Sharp & Dohme
11.2.1 Merck Sharp & Dohme Company Information
11.2.2 Merck Sharp & Dohme Pneumonia Therapeutics Product Offered
11.2.3 Merck Sharp & Dohme Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Merck Sharp & Dohme Main Business Overview
11.2.5 Merck Sharp & Dohme Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Pneumonia Therapeutics Product Offered
11.3.3 Novartis Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Pneumonia Therapeutics Product Offered
11.4.3 Pfizer Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Company Information
11.5.2 AstraZeneca Pneumonia Therapeutics Product Offered
11.5.3 AstraZeneca Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 AstraZeneca Main Business Overview
11.5.5 AstraZeneca Latest Developments
11.6 Bayer
11.6.1 Bayer Company Information
11.6.2 Bayer Pneumonia Therapeutics Product Offered
11.6.3 Bayer Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bayer Main Business Overview
11.6.5 Bayer Latest Developments
11.7 Biotest
11.7.1 Biotest Company Information
11.7.2 Biotest Pneumonia Therapeutics Product Offered
11.7.3 Biotest Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Biotest Main Business Overview
11.7.5 Biotest Latest Developments
11.8 Tetraphase Pharmaceuticals
11.8.1 Tetraphase Pharmaceuticals Company Information
11.8.2 Tetraphase Pharmaceuticals Pneumonia Therapeutics Product Offered
11.8.3 Tetraphase Pharmaceuticals Pneumonia Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Tetraphase Pharmaceuticals Main Business Overview
11.8.5 Tetraphase Pharmaceuticals Latest Developments
12 Research Findings and Conclusion
Table 1. Pneumonia Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Vaccines
Table 3. Major Players of Anti-Infectives
Table 4. Major Players of Oxygen Therapy
Table 5. Pneumonia Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Pneumonia Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Pneumonia Therapeutics Market Size Market Share by Type (2017-2022)
Table 8. Pneumonia Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Pneumonia Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Pneumonia Therapeutics Market Size Market Share by Application (2017-2022)
Table 11. Global Pneumonia Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Pneumonia Therapeutics Revenue Market Share by Player (2020-2022)
Table 13. Pneumonia Therapeutics Key Players Head office and Products Offered
Table 14. Pneumonia Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Pneumonia Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Pneumonia Therapeutics Market Size Market Share by Regions (2017-2022)
Table 19. Americas Pneumonia Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Pneumonia Therapeutics Market Size Market Share by Country (2017-2022)
Table 21. Americas Pneumonia Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Pneumonia Therapeutics Market Size Market Share by Type (2017-2022)
Table 23. Americas Pneumonia Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Pneumonia Therapeutics Market Size Market Share by Application (2017-2022)
Table 25. APAC Pneumonia Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Pneumonia Therapeutics Market Size Market Share by Region (2017-2022)
Table 27. APAC Pneumonia Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Pneumonia Therapeutics Market Size Market Share by Type (2017-2022)
Table 29. APAC Pneumonia Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Pneumonia Therapeutics Market Size Market Share by Application (2017-2022)
Table 31. Europe Pneumonia Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Pneumonia Therapeutics Market Size Market Share by Country (2017-2022)
Table 33. Europe Pneumonia Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Pneumonia Therapeutics Market Size Market Share by Type (2017-2022)
Table 35. Europe Pneumonia Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Pneumonia Therapeutics Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Pneumonia Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Pneumonia Therapeutics Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Pneumonia Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Pneumonia Therapeutics Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Pneumonia Therapeutics Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Pneumonia Therapeutics Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Pneumonia Therapeutics
Table 44. Key Market Challenges & Risks of Pneumonia Therapeutics
Table 45. Key Industry Trends of Pneumonia Therapeutics
Table 46. Global Pneumonia Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Pneumonia Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Pneumonia Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Pneumonia Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Pneumonia Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Pneumonia Therapeutics Market Size Market Share Forecast by Application (2023-2028)
Table 52. GlaxoSmithKline Details, Company Type, Pneumonia Therapeutics Area Served and Its Competitors
Table 53. GlaxoSmithKline Pneumonia Therapeutics Product Offered
Table 54. GlaxoSmithKline Pneumonia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. GlaxoSmithKline Main Business
Table 56. GlaxoSmithKline Latest Developments
Table 57. Merck Sharp & Dohme Details, Company Type, Pneumonia Therapeutics Area Served and Its Competitors
Table 58. Merck Sharp & Dohme Pneumonia Therapeutics Product Offered
Table 59. Merck Sharp & Dohme Main Business
Table 60. Merck Sharp & Dohme Pneumonia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Merck Sharp & Dohme Latest Developments
Table 62. Novartis Details, Company Type, Pneumonia Therapeutics Area Served and Its Competitors
Table 63. Novartis Pneumonia Therapeutics Product Offered
Table 64. Novartis Main Business
Table 65. Novartis Pneumonia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Novartis Latest Developments
Table 67. Pfizer Details, Company Type, Pneumonia Therapeutics Area Served and Its Competitors
Table 68. Pfizer Pneumonia Therapeutics Product Offered
Table 69. Pfizer Main Business
Table 70. Pfizer Pneumonia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Pfizer Latest Developments
Table 72. AstraZeneca Details, Company Type, Pneumonia Therapeutics Area Served and Its Competitors
Table 73. AstraZeneca Pneumonia Therapeutics Product Offered
Table 74. AstraZeneca Main Business
Table 75. AstraZeneca Pneumonia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. AstraZeneca Latest Developments
Table 77. Bayer Details, Company Type, Pneumonia Therapeutics Area Served and Its Competitors
Table 78. Bayer Pneumonia Therapeutics Product Offered
Table 79. Bayer Main Business
Table 80. Bayer Pneumonia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Bayer Latest Developments
Table 82. Biotest Details, Company Type, Pneumonia Therapeutics Area Served and Its Competitors
Table 83. Biotest Pneumonia Therapeutics Product Offered
Table 84. Biotest Main Business
Table 85. Biotest Pneumonia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Biotest Latest Developments
Table 87. Tetraphase Pharmaceuticals Details, Company Type, Pneumonia Therapeutics Area Served and Its Competitors
Table 88. Tetraphase Pharmaceuticals Pneumonia Therapeutics Product Offered
Table 89. Tetraphase Pharmaceuticals Main Business
Table 90. Tetraphase Pharmaceuticals Pneumonia Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Tetraphase Pharmaceuticals Latest Developments
List of Figures
Figure 1. Pneumonia Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pneumonia Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Pneumonia Therapeutics Market Size Market Share by Type in 2021
Figure 7. Pneumonia Therapeutics in Hospital
Figure 8. Global Pneumonia Therapeutics Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Pneumonia Therapeutics in Clinic
Figure 10. Global Pneumonia Therapeutics Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Pneumonia Therapeutics in Medical Center
Figure 12. Global Pneumonia Therapeutics Market: Medical Center (2017-2022) & ($ Millions)
Figure 13. Pneumonia Therapeutics in Other
Figure 14. Global Pneumonia Therapeutics Market: Other (2017-2022) & ($ Millions)
Figure 15. Global Pneumonia Therapeutics Market Size Market Share by Application in 2021
Figure 16. Global Pneumonia Therapeutics Revenue Market Share by Player in 2021
Figure 17. Global Pneumonia Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Pneumonia Therapeutics Market Size 2017-2022 ($ Millions)
Figure 19. APAC Pneumonia Therapeutics Market Size 2017-2022 ($ Millions)
Figure 20. Europe Pneumonia Therapeutics Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Pneumonia Therapeutics Market Size 2017-2022 ($ Millions)
Figure 22. Americas Pneumonia Therapeutics Value Market Share by Country in 2021
Figure 23. Americas Pneumonia Therapeutics Consumption Market Share by Type in 2021
Figure 24. Americas Pneumonia Therapeutics Market Size Market Share by Application in 2021
Figure 25. United States Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Pneumonia Therapeutics Market Size Market Share by Region in 2021
Figure 30. APAC Pneumonia Therapeutics Market Size Market Share by Application in 2021
Figure 31. China Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Pneumonia Therapeutics Market Size Market Share by Country in 2021
Figure 38. Europe Pneumonia Therapeutics Market Size Market Share by Type in 2021
Figure 39. Europe Pneumonia Therapeutics Market Size Market Share by Application in 2021
Figure 40. Germany Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Pneumonia Therapeutics Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Pneumonia Therapeutics Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Pneumonia Therapeutics Market Size Market Share by Application in 2021
Figure 48. Egypt Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Pneumonia Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. APAC Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. Europe Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. United States Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Canada Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. China Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Japan Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. Korea Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. India Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Australia Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. Germany Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. France Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. UK Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Italy Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Russia Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. Spain Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. Israel Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Pneumonia Therapeutics Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
